Pentamed® - High performance packaging films for medical devices

Quest Diagnostics and CDC Expand Partnership to Study Hepatitis C in the U.S.

Friday, December 08, 2023

Quest Diagnostics, a leading provider of diagnostic information services in the United States, recently announced that it successfully secured a contract from the Centers for Disease Control and Prevention (CDC) to assess the burden of hepatitis C virus (HCV) in the country. The contract, awarded after a competitive bidding process, signifies a continuation of the longstanding collaboration between Quest and the CDC, spanning over a decade. The primary objective of this partnership is to advance public health research related to hepatitis by leveraging insights derived from laboratory data.

The multi-year agreement empowers Quest to conduct both HCV antibody testing and molecular RNA testing on HIPAA-deidentified "remnant" specimens randomly selected from clinical test samples. The overarching goal is to gain a more comprehensive understanding of the prevalence of hepatitis C infection across the United States.

This collaboration underscores the efficacy of strategic public-private partnerships in influencing public health strategy, particularly in crucial health domains. Quest, a key player in hepatitis testing services, boasts a comprehensive test menu for hepatitis screening and monitoring assays. With the largest private laboratory database comprising over 60 billion data points, the company routinely collaborates with the CDC and academic experts to develop research initiatives, such as Quest Diagnostics Health Trends®, based on this valuable data. Through these efforts, Quest continues to contribute significantly to informing and shaping public health strategies.


Equinix accelerated medical research...Healthcare CEO & Executive Strategy SummitHealthcare CNO SummitHealthcare CMO SummitHealthcare CFO, Financial Strategy & Revenue Cycle SummitACO Leadership SummitThe Healthcare Patient Experience & Engagement Summit 2024Healthcare Innovation & Transformation Summit